SonR™: Long Term Clinical Update Confirms Risk Reduction

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SonR™: Long Term Clinical Update Confirms Risk Reduction in Heart Failure Hospitalization

LONDON, Aug. 28, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ:LIVN) (LSE:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced long term results from the RESPOND-CRT clinical trial after an 18 month follow-up period. The results were presented by the principal investigator, Prof. Josep Brugada, at an oral Clinical Trial Update session during the annual European Society of Cardiology (ESC) meeting.  The RESPOND-CRT trial was designed to investigate the clinical efficacy and safety of device-based optimization using LivaNova’s proprietary SonR cardiac contractility sensor technology in patients with advanced heart failure.

Previously, on May 5, 2016, LivaNova announced the RESPOND-CRT one-year results at the annual Heart Rhythm Society (HRS) and subsequently published a press release. The one-year data showed that the study met its primary safety and efficacy end points and demonstrated that SonR was associated with a 35% risk reduction in heart failure hospitalization.

Automatic optimization with SonR was compared to manual echocardiography guided optimization. The proprietary SonR optimization system allows for cardiac resynchronization therapy to be continuously adapted to the needs of each patient, thus delivering an individualized therapy.

Longer term results, after a complete 18 months patient follow-up, confirmed the significant risk reduction in heart failure hospitalization on the overall population enrolled in the study.  Additionally, in subgroups of patients with atrial fibrillation and renal dysfunctions, a 48% and 41% risk reduction in cardiovascular death or hospitalization was observed with SonR, respectively.

“We are very pleased to observe the consistent long-term clinical benefits of the SonR optimization system,” said Prof. Josep Brugada, MD, PhD, Cardiovascular Institute, Hospital Clínic, University of Barcelona, Spain.  “Reduction of hospitalization is key for heart failure patients.  The impressive improvements in cardiovascular clinical outcomes for patients with atrial fibrillation or renal dysfunction show that SonR can treat even better the sicker patients."

“The successful outcomes of the RESPOND-CRT study provides important data that we are pleased to share with the healthcare community,” said Benoît Clinchamps, LivaNova, Vice President, General Manager CRM. “LivaNova is committed to developing and delivering safe and effective technology to better treat heart failure patients. The SonR sensor-based optimization system fully resonates with this commitment.”

About the RESPOND-CRT Trial

The RESPOND-CRT study is a prospective, multicenter, randomized, double-blind study designed to evaluate the safety and efficacy of the SonR system.  The trial enrolled 1,039 patients at 125 sites in Europe, US and Australia who were implanted with a CRT-D device.  Patients were randomized 2:1 to receive AV or VV optimization either with SonR or echocardiography.  The primary analyses were performed at 12 months, secondary analysis were performed at 18 months.

The RESPOND-CRT trial is an Investigation Device Exemption (IDE) study approved by the Food and Drug Administration (FDA).  The study met all of its primary safety and efficacy end points.  The SonRtip lead was proven to be safe, with only 1% of patients reporting lead dislodgement and 0.1% of patients reporting lead fracture.  Optimization with SonR was proven to be as effective as echo-guided optimization based on responder rates.  Patients were defined as responders at 12 months based on a hierarchical set of criteria as follows: alive, free from heart failure events, with an improved NYHA functional class or quality of life.  Responder rates were 75% in the SonR arm and 70.4% in the Echo arm with [P <0.0001 non-inferiority].

The design of the trial has been published in the American Heart Journal, 2014.1

About SonR contractility sensor

The SonR sensor uses measurements of cardiac contractility in order to optimize cardiac resynchronization therapy.  The SonR cardiac contractility sensor consists of a micro accelerometer embedded in the tip of the SonRtip atrial lead.  The sensor continuously measures the vibrations generated by the myocardium during cardiac contractions which are correlated to cardiac contractility. 2,3,4

The SonR tip lead is connected to a LivaNova CRT-D device featuring an algorithm which automatically adapts the atrioventricular (AV) and interventricular (VV) intervals based on cardiac contractility measurements.  Optimization is performed on a weekly basis both at rest and during exercise.  This allows for cardiac resynchronization therapy to be continuously adapted to the individual needs of each patient.

SonR technology is available exclusively in LivaNova CRT-D devices including the Paradym, Intensia and Platinium families.  The new Platinium CRT-D SonR device was launched in Europe in November 2015.

References

  1. Brugada J, Brachmann J, Delnoy PP, et al. Automatic optimization of cardiac resynchronization therapy using SonR-rationale and design of the clinical trial of the SonRtip lead and automatic AV-VV optimization algorithm in the paradym RF SonR CRT-D (RESPOND-CRT) trial. Am Heart J 2014;167:429-36.
  2. Rickards AF, Bombardini T, Corbucci G et al. An implantable intracardiac accelerometer for monitoring myocardial contractility. The multicenter PEA Study group. Pacing Clin Electrophysiol 1996;19:2066-2071
  3. Bongiorni MG, Soldati E, Arena G et al. Local myocardial contractility related to endocardial acceleration signals detected by a transvenous pacing lead. Pacing Clin Electrophysiol 1996;19:1682-1688
  4. Bordachar P, Garrigue S, Ritter P et al. Contributions of a hemodynamic sensor embedded in an atrial lead in a porcine model. J Cardiovasc Elrctrophysiol. 2011;22(5):579-83

About LivaNova

LivaNova PLC is a global medical technology company formed by the merger of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation.  LivaNova transforms medical innovation into meaningful solutions for the benefit of patients, healthcare professionals, and healthcare systems.  The Company employs approximately 4,600 employees worldwide and is headquartered in London, U.K.  With a presence in more than 100 countries, LivaNova operates as three business units: Cardiac Surgery, Cardiac Rhythm Management, and Neuromodulation, with operating headquarters in Clamart (France), Mirandola (Italy) and Houston (U.S.), respectively.

LivaNova is listed on NASDAQ and is admitted to the standard listing segment of the Official List of the UK’s Financial Conduct Authority and to trading on the London Stock Exchange (LSE) under the ticker symbol “LIVN”.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended.  Forward-looking statements are not historical facts but are based on certain assumptions of management and describe our future plans, strategies and expectations.  Forward-looking statements can generally be identified by the use of forward-looking terminology, including, but not limited to, "may," “could,” “seek,” “guidance,” “predict,” “potential,” “likely,” "believe," "will," "expect," "anticipate," "estimate," "plan," "intend," "forecast," or variations of these terms and similar expressions, or the negative of these terms or similar expressions.  Forward-looking statements contained in this press release are based on information presently available to LivaNova and assumptions that LivaNova believes to be reasonable, but are inherently uncertain.  As a result, our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements.  Investors are cautioned that all such statements involve risks and uncertainties, including without limitation, the factors described in the “Risk Factors” section of LivaNova’s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other documents filed from time to time with, and/or announced or published pursuant to the rules of, the United States Securities and Exchange Commission and/or the United Kingdom Financial Conduct Authority by LivaNova, together with the risk that our internal leadership and organizational realignment will not lead to intended improvements, efficiency or results.  This list of factors is not exhaustive.  LivaNova does not give any assurance (1) that LivaNova will achieve its expectations, or (2) concerning any result or the timing thereof.

All information in this press release is as of the date of its release.  LivaNova does not undertake or assume any obligation to update publicly any of the forward-looking statements in this press release to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable law.  If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.  We caution you not to place undue reliance on any forward-looking statements, which are made only as of the date of this press release.

For more information, please visit www.livanova.com, or contact: Investor Relations and Media Karen King Vice President, Investor Relations & Corporate Communications Phone: +1 (281) 228-7262 Fax: +1 (281) 218-9332 e-mail: corporate.communications@livanova.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Giovanni Recalde Sues County After False Report

Updated Category News Views 215

Justice and Reputation: A Mix-Up Costs Big When the cops screw up, sometimes they really take the cake. That's what Giovanni Recalde learned, the hard way, when his name got tangled in a mess related to a gambling operation he wasn't even a part of. Prince William County police pasted his name into their daily incident report last year like it was no big deal. But it...

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 146

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
Vertiv's 800 VDC Push Gives AI Builders More Choices

Updated Category News Views 217

Electricity is becoming the awkward roommate inside every serious AI buildout, and Vertiv is trying to move it out of the rack before it eats the whole house. The company has expanded its 800 VDC offering beyond the PowerDirect 5000 rack product introduced in May 2026, laying out systems for the rack, the AI compute pod, and the full data hall. For investors following...

Continue Reading
ISDN Holdings: Leading APAC Automation with Innovation

Updated Category News Views 21

Pioneering Automation Intelligence in APAC Not every day you hear a company quietly revolutionizing an entire industry's landscape—but ISDN Holdings Limited is one of those rare players. Recognized by Frost & Sullivan for its top-tier customer value leadership, ISDN is making waves across the Asia-Pacific's industrial scene with its integrated industrial automation...

Continue Reading
Trilith Holiday Tour Blends Film Access and Giving

Updated Category News Views 39

Snow machines, trolley rides, and a mental-health subsidy are sharing the same stage in Fayetteville this holiday season. That is an unusual mix, but it fits Trilith Foundation’s stated mission better than another generic lights-and-cocoa event ever could. From Nov. 21 through Dec. 31, the Foundation is turning its guided Trilith Studios tour into a seasonal experience...

Continue Reading
Wonder Create: Democratizing Restaurant Creation

Updated Category News Views 32

Breaking Down Barriers in the Restaurant Industry It's been a long time since someone truly shook up the restaurant scene like this. Wonder Create is stepping in to turn anyone with a wild food idea into a bonafide restaurateur. We're not talking about the ol' franchising route here. We're diving straight into democratizing the culinary world. You seen something this bold...

Continue Reading
Voltage Energy's Microgrid Launches at RE+ 2026

Updated Category News Views 25

Voltage Energy Unveils New Power Systems In the swirling chaos of energy innovation, Voltage Energy is trying to carve its path at the heart of RE+ 2026. Out in Las Vegas, amidst the buzz of renewable energy tech, they introduced their Microgrid System (MGS) along with two new electrical balance of system (EBOS) products—the Load Break Disconnect Box (LBD) and Combiner...

Continue Reading
Inhabit Puts AI Across Its Property Management Stack

Updated Category News Views 72

Property managers do not need another shiny chatbot; they need fewer dropped leads, fewer invoice-entry mistakes and less staff time burned chasing routine answers. That is the sensible hook in Inhabit's OPTECH 2026 announcement. The company is spreading AI, integrations and scalability work across ResMan, Anyone Home, ePremium, Nationwide Compliant and several adjacent...

Continue Reading
Azazie Tests Bridal Demand With Two East Coast Pop-Ups

Updated Category News Views 58

Wedding dresses are a miserable product to buy sight unseen, no matter how pretty the product photos look. That basic fact is why Azazie’s two East Coast pop-ups on November 21 and 22 deserve a closer look. This is not some grand retail rollout, and nobody should pretend a pair of short events rewrites the bridal market. But it is a practical test of where a...

Continue Reading
Bona's 2027 Floorcast Finds Wood and Trust Still Win

Updated Category News Views 132

Floors are turning into a long-game purchase again Gray flooring may be limping toward the exit, but the more important signal in Bona's 2027 Floorcast is that homeowners are thinking less like bargain hunters and more like custodians of an expensive asset. That is a useful read for anybody watching the home-improvement and maintenance landscape. People do not replace a...

Continue Reading

Top 5 Most Recently Viewed Articles

Estimating the Growth of $100 in Webster Financial Shares

Updated Category News Views 237

Understanding Webster Financial's Long-Term Growth Webster Financial, trading under the symbol WBS, has demonstrated a remarkable performance in the stock market over the past five years. The investment landscape can be unpredictable, but looking at WBS, we can observe that it has outperformed the market by an average of 3.91% annually, yielding a total annual return of...

Continue Reading
Grocery Outlet Shareholders Can Pursue Securities Fraud Claims

Updated Category News Views 129

Grocery Outlet Shareholders Can Pursue Securities Fraud Claims Investors have the chance to reclaim their losses after allegations of securities fraud at Grocery Outlet Holding Corp. (NASDAQ: GO). It’s crucial for all purchasers of Grocery Outlet securities who were active during the defined Class Period to understand their rights. Understanding the Class Period The...

Continue Reading
Core Bank Expands Services with New Banking Center Soon

Updated Category News Views 135

Core Bank Relocation to a New Overland Park Facility Core Bank is thrilled to announce its move to a new location for its Overland Park Banking Center. This relocation marks a significant milestone for the bank, allowing it to better serve the growing needs of the community. The modern banking space, set to open soon, is designed with improved accessibility and enhanced...

Continue Reading
Exploring Netflix's Recent Options Activity and Insights

Updated Category News Views 189

Netflix's Recent Options Trading Trends Financial giants have expressed a notable bullish sentiment toward Netflix. Analyzing the recent options trades for Netflix (NASDAQ: NFLX) reveals that 65 unusual trades have taken place, sparking considerable interest among investors. Traders' Sentiments and Volume Analysis Diving into the details, about 56% of traders exhibited...

Continue Reading
Simply Good Foods Faces Securities Fraud Lawsuit Turmoil

Updated Category News Views 53

Simply Good Foods: Murky Waters  Well, here we go again with yet another corporate mess. Simply Good Foods Company’s staring down a securities class action lawsuit over not-so-savory business moves that have knocked their stock into the gutter. The beef? Failing to spill the beans on troubles brewing from an acquisition that's gone south. Now, they’re facing a...

Continue Reading